3 Results for "

Hsp70-Bim

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "Hsp70-Bim" in MCE Product Catalog:

Cat. No.: HY-163854
CAS No.: 3048341-44-9
Target:  

HSP Apoptosis

Research Areas:  

Cancer

HSP70-IN-6 (JL-15) is an inhibitor of Hsp70-Bim protein-protein interaction, with an IC50 value of 0.07 μM against Hsp70-Bim PPI, an IC50 of 4.89 μM and a Kd of 0.123 μM for BimBH3-stimulated Hsp70 ATPase activity. HSP70-IN-6 selectively blocks the binding of Hsp70-Bim without affecting the Hsp70-Bag3 interaction, and inhibits BimBH3-stimulated Hsp70 ATPase activity but has no impact on basal ATPase activity. HSP70-IN-6 induces apoptosis (apoptosis) in chronic myeloid leukemia cells in an Hsp70-Bim-dependent manner. HSP70-IN-6 can be used in research related to chronic myeloid leukemia .
loading...
    loading...
Cat. No.: HY-162008
CAS No.: 3032432-71-3
Target:  

HSP Autophagy Apoptosis

Research Areas:  

Cancer

S1g-10 is an Hsp70-Bim protein-protein interaction inhibitor and an Hsp70 ATPase inhibitor. S1g-10 binds the Hsp70 nucleotide-binding domain at the Bim interface, inhibits Bim-stimulated ATPase activity, and selectively disrupts Hsp70-Bim without affecting Hsp70-Bag3, thereby inhibiting mitophagy (Autophagy), inducing apoptosis (Apoptosis), and reducing the survival and self-renewal of CML leukemia stem cells. S1g-10 can be used for research on chronic myeloid leukemia and breast cancer .
loading...
    loading...
Cat. No.: HY-189700
CAS No.: 3048341-50-7
JL-15-DNBS is an Hsp70-Bim interaction disruptor. JL-15-DNBS undergoes GSH-responsive activation to release active JL-15, and GSH depletion attenuates its cytotoxicity. JL-15-DNBS downregulates the oncogenic client proteins AKT and eIF4E. JL-15-DNBS can be used for research on chronic myeloid leukemia (CML) .
loading...
    loading...